Pearl White

Potassium Nitrate, Sodium Fluoride


Beyond International Inc.
Human Otc Drug
NDC 42199-006
Pearl White also known as Potassium Nitrate, Sodium Fluoride is a human otc drug labeled by 'Beyond International Inc.'. National Drug Code (NDC) number for Pearl White is 42199-006. This drug is available in dosage form of Paste, Dentifrice. The names of the active, medicinal ingredients in Pearl White drug includes Potassium Nitrate - 50 mg/g Sodium Fluoride - 1 mg/g . The currest status of Pearl White drug is Active.

Drug Information:

Drug NDC: 42199-006
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Pearl White
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Potassium Nitrate, Sodium Fluoride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Beyond International Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Paste, Dentifrice
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:POTASSIUM NITRATE - 50 mg/g
SODIUM FLUORIDE - 1 mg/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:DENTAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 12 Jun, 2017
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 09 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part356
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Beyond International Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:RU45X2JN0Z
8ZYQ1474W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
42199-006-051 TUBE in 1 CARTON (42199-006-05) / 120 g in 1 TUBE12 Jun, 2017N/ANo
42199-006-061 TUBE in 1 CARTON (42199-006-06) / 40 g in 1 TUBE12 Jun, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose antihypersensitivity anticavity

Product Elements:

Pearl white potassium nitrate, sodium fluoride sorbitol hydrated silica water propanediol sodium lauryl sulfate polyethylene glycol 400 hydroxyethyl cellulose (5000 mpa.s at 1%) gaultheria procumbens leaf sodium benzoate titanium dioxide saccharin sodium calcium peroxide starch, corn potassium nitrate nitrate ion sodium fluoride fluoride ion polyethylene glycol 1450 carboxymethylcellulose sodium

Indications and Usage:

Uses helps reduce painful sensitivity of the teeth to cold, heat, acids, sweets or contact. aids in the prevention of dental cavities.

Warnings:

Warnings

Dosage and Administration:

Directions adults and children 12 years of age and older apply at least a 1-inch strip of toothpaste onto a soft bristle toothbrush. brush teeth thoroughly for at least 1 minute twice a day (morning and evening), and not more than 3 times a day, or as directed by a dentist or doctor. do not swallow. spit out after brushing. children under 12 years of age: consult a dentist or doctor.

Stop Use:

Stop use and ask a dentist if the problem persists or worsens. sensitive teeth may indicate a serious problem that may need prompt care by a dentist. pain/sensitivity still persists after 4 weeks of use.

Package Label Principal Display Panel:

Pearl white sensitivity whitening toothpaste with fluoride net wt. 4.76 oz. (135 g) toothpaste pearl white

Further Questions:

Questions or comments? 866-695-6452


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.